Company / Free Cash Flow per Share
Corvus Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.50
FY2023
5-year range
-$1.18 / -$0.50
FY2019-FY2023
Trend
+14.9%
vs FY2022
Sector context
#88 of 190
Health Care
What the data says
At $-0.50, Corvus Pharmaceuticals, Inc.'s free cash flow per share ranks #88 of 190 in the Health Care sector. Free Cash Flow per Share has increased for 6 consecutive years, from $-2.27 in FY2017 to $-0.50 in FY2023.
Based on SEC 10-K filings.
-0.50 in FY2023.
Improved from $-0.88 to $-0.50 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#88 of 190 in Health CareTop 46% of 190This company -$0.50 Sector average $3.32
▼
-115.0% below sector average
Key checks
Key Insights
- Corvus Pharmaceuticals, Inc.'s free cash flow per share has grown for 6 consecutive years.
- In FY2023, free cash flow per share increased 14.9% year-over-year.
- Ranks #88 out of 190 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$0.50 | +14.9% |
| FY2022 | -$0.59 | +33.2% |
| FY2021 | -$0.88 | +25.8% |
| FY2020 | -$1.18 | +7.1% |
| FY2019 | -$1.27 | +15.3% |
| FY2018 | -$1.50 | +33.8% |
| FY2017 | -$2.27 | -16.4% |
| FY2016 | -$1.95 | +94.4% |
| FY2015 | -$34.99 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026